The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection of early-stage urothelial cancers using methylation patterns in urine cell-free DNA.
 
Tyler Stewart
Consulting or Advisory Role - AstraZeneca; Seattle Genetics/Astellas
Research Funding - GRAIL
 
Archana Shenoy
Employment - GRAIL
Stock and Other Ownership Interests - Gilead Sciences (I); Illumina; Novartis (I); Personalis (I)
 
Rojin Safavi
Employment - GRAIL; Natera (I)
Stock and Other Ownership Interests - Natera (I)
Travel, Accommodations, Expenses - Natera (I)
 
Sarah Stuart
Employment - Grail
Stock and Other Ownership Interests - Illumina/GRAIL
Patents, Royalties, Other Intellectual Property - Digital microfluidic system for single-cell isolation and characterization of analytes
 
Kelly McClintock
Employment - Grail
Stock and Other Ownership Interests - Illumina
Patents, Royalties, Other Intellectual Property - ROCHE - SINGLE TUBE PREPARATION OF DNA AND RNA FOR SEQUENCING
 
Amani Alchaar
No Relationships to Disclose
 
Aditya Bagrodia
Consulting or Advisory Role - Ferring; Veracyte
 
Karim Kader
No Relationships to Disclose
 
Rana McKay
Consulting or Advisory Role - Ambrx; Ambrx; Arcus Biosciences; Astellas Medivation; AstraZeneca; AVEO; Bayer; Blue Earth Diagnostics; Bristol-Myers Squibb; Calithera Biosciences; Caris Life Sciences; Dendreon; Esiai; Exelixis; Janssen; Lilly; Merck; Myovant Sciences; NeoMorph; Novartis; Pfizer; Sanofi; Seagen; Sorrento Therapeutics; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tempus; Vividion Therapeutics
Research Funding - Artera (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb (Inst); Exelixis (Inst); Oncternal Therapeutics (Inst); Tempus (Inst)
 
Neil Recio
No Relationships to Disclose
 
Heidi Wagner
No Relationships to Disclose
 
Neil Fleshner
No Relationships to Disclose
 
Matthew Larson
Employment - GRAIL
Stock and Other Ownership Interests - Illumina/GRAIL
 
Amirali Salmasi
No Relationships to Disclose